ProductLife Group expands life science services with milestone Pharma D&S acquisition

Published: 16-Jun-2023

ProductLife Group has agreed the acquisition of the Italian company Pharma D&S Group which is a global provider of regulatory and compliance services for the life sciences industry

ProductLife Group (PLG), the global and specialised provider of regulatory, vigilance and quality management services for the pharmaceutical, biotech and medtech industries, has announced its intention to merge with Pharma D&S Group, the leading Italian player in the industry.

Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner. It strengthened its service offering on regulatory affairs, product quality and process compliance, pharmacovigilance and clinical operations activities.

In 2004, the Group launched Pharma Education Center (PEC), a training provider for the Life Sciences sector. In 2005, the two partners were joined by Marco Conti who founded C&P Engineering a consulting entity providing high-quality services specialized in pharmaceutical process engineering, qualification and computer systems validation.

The merger with PLG provides our clients and the life sciences industry with access to a global footprint and a more robust combined set of capabilities across all of our key value areas

- Riccardo Ballerini, Founder and Chairman of Pharma D&S

This new deal is a key step in PLG's growth, making up for a company of more than one thousand and two hundred employees with a strong and expert presence across the globe. For Xavier Duburcq, CEO of PLG, "Pharma D&S Group is a renowned leader in the Italian market with a long standing emphasis on quality and expertise. The synergies between our two companies are high, and our values and corporate cultures have a lot in common, thanks to the entrepreneurial spirit at both PLG and Pharma D&S Group."

"Twenty years after launching Pharma D&S Group, I am convinced that joining PLG is the future of our organisation", says Riccardo Ballerini, Founder and Chairman of Pharma D&S. "The merger with PLG provides our clients and the life sciences industry with access to a global footprint and a more robust combined set of capabilities across all of our key value areas".

Like this story? Subscribe to Manufacturing Chemist magazine for the latest news, updates and expert-written articles from the global pharmaceutical and biopharma sectors. For more information click here.

Lino Fabrizi, COO of Pharma D&S, further shares: "This strategic alliance will provide a good opportunity for our team to expand their careers, and it will give our business strong support functions to facilitate sustainable growth. We strongly believe that our two organizations share the same DNA which will result in a stronger quality of service provided to our clients."

For Marco Conti, Founder and CEO of C&P Engineering, "being part of PLG is the opportunity to provide our tailored made quality design and qualification expertise to a wider range of clients across Europe, enlarging the offering and leveraging the strong network that PLG already has today."

You may also like